Contact
Please use this form to send email to PR contact of this press release:
SF3B1 mutation-mediated sensitization to H3B-8800 splicing inhibitor in chronic lymphocytic leukemia
TO:
Please use this form to send email to PR contact of this press release:
SF3B1 mutation-mediated sensitization to H3B-8800 splicing inhibitor in chronic lymphocytic leukemia
TO: